Cost-Effectiveness of Surgically Induced Weight Loss for the Management of Type 2 Diabetes: Modeled Lifetime Analysis

被引:108
作者
Keating, Catherine L. [1 ,2 ]
Dixon, John B. [1 ,3 ]
Moodie, Marjory L. [2 ]
Peeters, Anna [1 ,4 ]
Bulfone, Liliana [2 ]
Maglianno, Dianna J. [3 ,4 ]
O'Brien, Paul E. [1 ]
机构
[1] Monash Univ, Ctr Obes Res & Educ, Melbourne, Vic 3004, Australia
[2] Deakin Univ, Hlth Econ Unit, Melbourne, Vic, Australia
[3] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia
[4] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
关键词
LONG-TERM MORTALITY; QUALITY-OF-LIFE; GASTRIC BYPASS; SURGERY; OBESITY; STYLE; RISK;
D O I
10.2337/dc08-1749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To estimate the cost-effectiveness of surgically induced weight loss relative to conventional therapy for the management of recently diagnosed type 2 diabetes in class I/II obese patients. RESEARCH DESIGN AND METHODS - This study builds on a within-trial cost-efficacy analysis. The analysis compares the lifetime costs and quality-adjusted life-years (QALYs) between the two intervention groups. Intervention costs were extrapolated based oil observed resource utilization during the trial. The proportion of patients in each intervention group with remission of diabetes at 2 years was the same as that observed in the trial, Health care costs for patients with type 2 diabetes and outcome variables required to derive estimates of QALYs were sourced from published literature. A health care system perspective was adopted. Costs and outcomes were discounted annually at 3%. Costs are presented in 2006 Australian dollars (AUD) (currency exchange: 1 AUD = 0.74 USD). RESULTS - The mean number of years in diabetes remission over a lifetime was 11.4 for surgical therapy patients and 2.1 for conventional therapy patients. Over the remainder of their lifetime, surgical and conventional therapy patients lived 15.7 and 14.5 discounted QALYs, respectively. The mean discounted lifetime costs were 98,900 AUD per surgical therapy patient and 101,400 AUD per conventional therapy patient. Relative to conventional therapy, surgically induced weight loss was associated with a mean health care saving of 2,400 AUD and 1.2 additional QALYs per patient. CONCLUSIONS - Surgically induced weight loss is a dominant intervention (it both saves health care costs and generates health benefits) for managing recently diagnosed type 2 diabetes in class I/II obese patients in Australia.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 26 条
  • [1] Long-term mortality after gastric bypass surgery
    Adams, Ted D.
    Gress, Richard E.
    Smith, Sherman C.
    Halverson, R. Chad
    Simper, Steven C.
    Rosamond, Wayne D.
    LaMonte, Michael J.
    Stroup, Antoinette M.
    Hunt, Steven C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) : 753 - 761
  • [2] *AUSTR GOV DEP HLT, 2006, MED BEN SCHED ALL HL
  • [3] *AUSTR GOV DEP HLT, 2006, SCHED PHARM BEN APPR
  • [4] *AUSTR I HLTH WELF, 2007, HLTH EXP AUSTR 2005, V30
  • [5] Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
    Christou, NV
    Sampalis, JS
    Liberman, M
    Look, D
    Auger, S
    McLean, APH
    MacLean, LD
    [J]. ANNALS OF SURGERY, 2004, 240 (03) : 416 - 423
  • [6] Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation
    Clegg, A
    Colquitt, J
    Sidhu, M
    Royle, P
    Walker, A
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 2003, 27 (10) : 1167 - 1177
  • [7] Colagiuri S., 2003, DiabCost Australia: Assessing the Burden of Type 2 Diabetes in Australia
  • [8] Cremieux PY, 2008, AM J MANAG CARE, V14, P589
  • [9] Dall T., 2008, Diabetes Care, V31, P1, DOI DOI 10.2337/DC07-2052
  • [10] Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding
    Dixon, JB
    O'Brien, PE
    [J]. DIABETES CARE, 2002, 25 (02) : 358 - 363